Project ID: D2016-26IP Status: PCT patent application filed Invention Description and Novelty: Canavan disease is a neurological disease caused by an interruption in the metabolism of N-acetylaspartate (NAA). Numerous mutations have been found in the enzyme that hydrolyzes NAA, and the catalytic act.....
[更多]
Lead Inventors: Peng Wang, Ph.D., Jeffrey T. Koberstein Ph.D.Problem or Unmet Need:It is desirable to design and control the structure and properties of surfaces and interfaces without affecting a material's bulk properties. Few current techniques for surface modification, however, allow for specifi.....
[更多]
Ioannis (John) Kymissis, Ph.D.
[更多]
In vitro disease modeling, drug screening.
[更多]
Improved delivery of drugs or other substances through a surfaceContinuous in situ sampling without the complications of lancetsCustomized lengths for access to interstitial fluid bathing the epidermal cells (200-250 micron length) or whole blood from dermal capillaries (250-350 micron length)Micron.....
[更多]
| |< <- | [6503] [6504] [6505] [6506] [6507] [6508] [6509] [6510] [6511] [6512] [6513] | -> >| |
